Osimertinib vs Rabeprazole
Osimertinib vs Rabeprazole: Overview
This comparison examines the pharmacological differences between Osimertinib and Rabeprazole.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Rabeprazole: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.
Pharmacokinetics
Half-life: Osimertinib β 48 hours; Rabeprazole β 1-2 hours.
Chemical Properties
Molecular Formula: Osimertinib β C28H33N7O2; Rabeprazole β C18H21N3O3S.
Molecular Weight: Osimertinib β 499.6050 g/mol; Rabeprazole β 359.4440 g/mol.
Type: Osimertinib β Small molecule; Rabeprazole β Small molecule.